Dunkel E C, Pavan-Langston D, Fitzpatrick K, Cukor G
Department of Ophthalmology, Harvard Medical School, Boston, MA 02114.
Curr Eye Res. 1988 Jul;7(7):661-6. doi: 10.3109/02713688809033194.
The new HERPCHEK (Dupont, No. Billerica, MA) enzyme immunosorbent assay (EIA) was used in a double-blind clinical study for rapid and specific detection of ocular herpes simplex virus (HSV) infection. This 4-hour assay can be used to demonstrate conclusively the presence of HSV antigen without culture and thereby rapidly differentiate between HSV and other clinically similar ocular infectious diseases. Ocular samples were collected from 180 individuals including 30 patients with acute HSV, 90 with latent HSV (ie, currently asymptomatic but with a positive history), 11 with acute or latent varicella zoster virus, 30 with nonherpetic infections (due to adenovirus, Acanthamoeba or bacteria), and 19 normal controls. A clinical diagnosis was made by one of us (DPL) and duplicate tear-film samples obtained by swabbing the conjunctival cul-de-sac and cornea. Coded samples were tested by routine viral culture on Vero cell monolayers and also were run independently in the HERPCHEK test. During active HSV infection, the HERPCHEK correlated 100% with clinical diagnosis, and virus culture correlated 90% with clinical diagnosis. In all latent HSV ocular infections, other nonherpetic ocular infections and normal samples, both the HERPCHEK and culture assays were negative.
新型HERPCHEK(杜邦公司,马萨诸塞州比勒里卡)酶免疫吸附测定(EIA)用于一项双盲临床研究,以快速、特异性地检测眼部单纯疱疹病毒(HSV)感染。这项耗时4小时的检测可用于在不进行培养的情况下确凿地证明HSV抗原的存在,从而快速区分HSV与其他临床症状相似的眼部传染病。从180名个体中采集眼部样本,其中包括30例急性HSV患者、90例潜伏性HSV患者(即目前无症状但有阳性病史)、11例急性或潜伏性水痘带状疱疹病毒患者、30例非疱疹性感染患者(由腺病毒、棘阿米巴或细菌引起)以及19名正常对照者。由我们中的一人(DPL)做出临床诊断,并通过擦拭结膜穹窿和角膜获取双份泪膜样本。编码后的样本在Vero细胞单层上进行常规病毒培养检测,同时也独立进行HERPCHEK检测。在HSV活跃感染期间,HERPCHEK与临床诊断的相关性为100%,病毒培养与临床诊断的相关性为90%。在所有潜伏性HSV眼部感染、其他非疱疹性眼部感染和正常样本中,HERPCHEK检测和培养检测均为阴性。